Screener
Dyne Therapeutics, Inc. DYN Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Dyne Therapeutics, Inc.’s reported figures.
The source filing: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 7:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215702
FAQ
- What is Dyne Therapeutics, Inc.'s invested capital?
- Dyne Therapeutics, Inc. (DYN) reported invested capital of $280.63M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s invested capital changed year-over-year?
- Dyne Therapeutics, Inc.'s invested capital increased by 27.5% year-over-year, from $220.05M to $280.63M.
- What is the long-term trend for Dyne Therapeutics, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s invested capital has grown at a 42.4% compound annual growth rate (CAGR), from $42.32M to $247.96M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Dyne Therapeutics, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude